nach oben

Erschienen in:

19.07.2021 | Correction

Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization

verfasst von: Sharmila Dorbala, MD, MPH, FASNC (Chair), Yukio Ando, MD, PhD, Sabahat Bokhari, MD, Angela Dispenzieri, MD, Rodney H. Falk, MD, Victor A. Ferrari, MD, Marianna Fontana, PhD, Olivier Gheysens, MD, PhD, Julian D. Gillmore, MD, PhD, Andor W. J. M. Glaudemans, MD, PhD, Mazen A. Hanna, MD, Bouke P. C. Hazenberg, MD, PhD, Arnt V. Kristen, MD, Raymond Y. Kwong, MD, MPH, Mathew S. Maurer, MD, Giampaolo Merlini, MD, Edward J. Miller, MD, PhD, James C. Moon, MD, Venkatesh L. Murthy, MD, PhD, C. Cristina Quarta, MD, PhD, Claudio Rapezzi, MD, Frederick L. Ruberg, MD, Sanjiv J. Shah, MD, Riemer H. J. A. Slart, MD, Hein J. Verberne, MD, PhD, Jamieson M. Bourque, MD, MHS, FASNC (Co-Chair)

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Excerpt

In the Introduction SCMR was listed incorrectly. SCMR is the Society for Cardiovascular Magnetic Resonance.
Table 1. Criteria for Diagnosis, ‘Clinical Diagnosis of ATTR…,’ number should begin with “1.”
Table 2. Erroneously printed without Clinical scenario 7. ‘Prior testing suggestive of cardiac amyloidosis.’ Please see revised Table 2.

Table 2
Appropriate utilization rating of multimodality imaging for the assessment of cardiac amyloidosis

A, appropriate; AL, amyloidogenic light chain; ATTR, amyloidogenic transthyretin; bone scintigraphy, ^99mTc pyrophosphate (PYP), ^99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD), ^99mTc-hydroxymethylene diphosphonate (HMDP); CMR, cardiac magnetic resonance; Echo, echocardiography; LV, left ventricular; MGUS, Monoclonal gammopathy of uncertain significance; M, maybe appropriate; NA, not assessed; NT-pro BNP, N-terminal pro-brain natriuretic peptide; R, rarely appropriate.

*Time interval may vary based on the clinical status of the patient and local clinical practice.

**Although most patients with cardiac amyloidosis will have preserved LV ejection fraction or “paradoxical” low-flow, low-gradient AS, LV ejection fraction may be reduced or mid-range in some cases.

^†Indicates lack of consensus for rating among experts.
Acknowledgments erroneously printed without reviewers Richard Cheng, MD and Roy John, MD.
Reference 8. This article is now published. The citation is:

Knight DS, Zumbo G, Barcella W, Steeden JA, Muthurangu V, Martinez-Naharro A, et al. Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles. JACC Cardiovasc Imaging 2019;12(5):823-33.
Reference 22. updated:

Rowczenio D, Wechalekar. A Mutations in Hereditary Amyloidosis. 2015. Available at http://amyloidosismutations.com/mut-attr.php

…

Titel: Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization
verfasst von: Sharmila Dorbala, MD, MPH, FASNC (Chair)
Yukio Ando, MD, PhD
Sabahat Bokhari, MD
Angela Dispenzieri, MD
Rodney H. Falk, MD
Victor A. Ferrari, MD
Marianna Fontana, PhD
Olivier Gheysens, MD, PhD
Julian D. Gillmore, MD, PhD
Andor W. J. M. Glaudemans, MD, PhD
Mazen A. Hanna, MD
Bouke P. C. Hazenberg, MD, PhD
Arnt V. Kristen, MD
Raymond Y. Kwong, MD, MPH
Mathew S. Maurer, MD
Giampaolo Merlini, MD
Edward J. Miller, MD, PhD
James C. Moon, MD
Venkatesh L. Murthy, MD, PhD
C. Cristina Quarta, MD, PhD
Claudio Rapezzi, MD
Frederick L. Ruberg, MD
Sanjiv J. Shah, MD
Riemer H. J. A. Slart, MD
Hein J. Verberne, MD, PhD
Jamieson M. Bourque, MD, MHS, FASNC (Co-Chair)
Publikationsdatum: 19.07.2021
Verlag: Springer International Publishing
Erschienen in: Journal of Nuclear Cardiology / Ausgabe 4/2021
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-021-02712-9

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization

Excerpt

Neu im Fachgebiet Kardiologie

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Schadet Ärger den Gefäßen?

Intervallfasten zur Regeneration des Herzmuskels?

Update Kardiologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2021

Robert A. Bruce MD (1914-2004)

The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review

A positive PYP scan: Thinking beyond amyloid

Myocardial blood flow: Is motion correction necessary?

Men are from Mars and women are from Venus: The nuclear cardiology point of view

High quality attenuation-corrected myocardial perfusion images may be achieved in patients with morbid obesity using a whole-body CZT camera and a low-dose injection protocol

Neu im Fachgebiet Kardiologie

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Schadet Ärger den Gefäßen?

Intervallfasten zur Regeneration des Herzmuskels?

Update Kardiologie